The pharmaceutical industry invested heavily in developing stable, injectable versions of GLP-1 that could mimic the hormone's effects in the human body
Patients with past instances of pancreatitis or significant gastrointestinal challenges should discuss other routes with their providers in Bluffton
Subsequent studies have shown that this phenomenon could be linked to a slowing of gastric emptying by GLP-1, as well as by the action of this hormone at the level of certain neural circuits of the brain involved in the suppression of appetite and the development of nausea
For example, PINK1 and Parkin loss of function impair mitophagy and cause accumulation of damaged mitochondria, leading to enhanced electron leakage and formation of superoxides 11,12,13
The step-wise progression exists because higher doses produce stronger appetite suppression and metabolic effects, but also increase the likelihood of side effects like nausea or gastrointestinal discomfort